相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Synonymous mutations and the molecular evolution of SARS-CoV-2 origins
Hongru Wang et al.
VIRUS EVOLUTION (2021)
Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020
Helle Daugaard Larsen et al.
EUROSURVEILLANCE (2021)
Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs
Paolo Calistri et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey et al.
LANCET (2021)
Detection of a SARS-CoV-2 variant of concern in South Africa
Houriiyah Tegally et al.
NATURE (2021)
SARS-CoV-2 evolution during treatment of chronic infection
Steven A. Kemp et al.
NATURE (2021)
The effectiveness of backward contact tracing in networks
Sadamori Kojaku et al.
NATURE PHYSICS (2021)
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
Kai Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies et al.
SCIENCE (2021)
SARS-CoV-2 within-host diversity and transmission
Katrina A. Lythgoe et al.
SCIENCE (2021)
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Chadi M. Saad-Roy et al.
SCIENCE (2021)
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
Kevin R. McCarthy et al.
SCIENCE (2021)
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Robert Challen et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Population Genomics Insights into the First Wave of COVID-19
Maria Vasilarou et al.
LIFE-BASEL (2021)
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
Xianding Deng et al.
CELL (2021)
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Nicholas G. Davies et al.
NATURE (2021)
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Erik Volz et al.
NATURE (2021)
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
Laith J. Abu-Raddad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The emerging plasticity of SARS-CoV-2
Kevin D. McCormick et al.
SCIENCE (2021)
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria et al.
SCIENCE (2021)
A human coronavirus evolves antigenically to escape antibody immunity
Rachel T. Eguia et al.
PLOS PATHOGENS (2021)
Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members - Chicago, Illinois, December 2020-March 2021
Richard A. Teran et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Modelling the impact of shutdowns on resurging SARS-CoV-2 transmission in Canada
Victoria Ng et al.
ROYAL SOCIETY OPEN SCIENCE (2021)
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination
Sarah Cobey et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Synonymous mutations and the molecular evolution of SARS-CoV-2 origins
Hongru Wang et al.
VIRUS EVOLUTION (2021)
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni et al.
CELL (2020)
On the evolutionary epidemiology of SARS-CoV-2
Troy Day et al.
CURRENT BIOLOGY (2020)
Evidence for transmission of COVID-19 prior to symptom onset
Lauren C. Tindale et al.
ELIFE (2020)
De-Escalation by Reversing the Escalation with a Stronger Synergistic Package of Contact Tracing, Quarantine, Isolation and Personal Protection: Feasibility of Preventing a COVID-19 Rebound in Ontario, Canada, as a Case Study
Biao Tang et al.
BIOLOGY-BASEL (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
Gideon Meyerowitz-Katz et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates
Joana Damas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
Victoria A. Avanzato et al.
CELL (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2
Lucy van Dorp et al.
NATURE COMMUNICATIONS (2020)
Superspreading events in the transmission dynamics of SARS-CoV-2: Opportunities for interventions and control
Benjamin M. Althouse et al.
PLOS BIOLOGY (2020)
Emerging infectious diseases and biological invasions: a call for a One Health collaboration in science and management
Nick H. Ogden et al.
ROYAL SOCIETY OPEN SCIENCE (2019)
Nextstrain: real-time tracking of pathogen evolution
James Hadfield et al.
BIOINFORMATICS (2018)
Why does drug resistance readily evolve but vaccine resistance does not?
David A. Kennedy et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Risk factors for the evolutionary emergence of pathogens
H. K. Alexander et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2010)
Invasion thresholds and the evolution of nonequilibrium virulence
James J. Bull et al.
EVOLUTIONARY APPLICATIONS (2008)
Applying population-genetic models in theoretical evolutionary epidemiology
Troy Day et al.
ECOLOGY LETTERS (2007)
A single positively selected West Nile viral mutation confers increased virogenesis in American crows
Aaron C. Brault et al.
NATURE GENETICS (2007)
Superspreading and the effect of individual variation on disease emergence
JO Lloyd-Smith et al.
NATURE (2005)